Showing results (181-190 of 265) with videos related to

Sort By:
Pageof 27
World Journal of Surgery|February 11, 2015
Feeding duodenostomy decreases the incidence of mechanical obstruction after radical esophageal cancer surgeryHisaharu Oya, Masahiko Koike, Naoki Iwata, et al.
Oncology Letters|February 10, 2015
Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomyRyoji Hashimoto, Mitsuro Kanda, Hideki Takami, et al.
Cancer Chemotherapy and Pharmacology|March 1, 2014
The impact of dose/time modification in irinotecan- and oxaliplatin-based chemotherapies on outcomes in metastatic colorectal cancerGoro Nakayama, Chie Tanaka, Keisuke Uehara, et al.
International Journal of Clinical Oncology|September 23, 2019
Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)Norifumi Hattori, Goro Nakayama, Keisuke Uehara, et al.
Anticancer Research|April 3, 2020
Exploration of Exosomal Micro RNA Biomarkers Related to Epithelial-to-Mesenchymal Transition in Pancreatic CancerFuminori Sonohara, Suguru Yamada, Shigeomi Takeda, et al.
International Journal of Oncology|November 19, 2014
B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinomaMitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, et al.
Oncotarget|February 13, 2016
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancerMitsuro Kanda, Dai Shimizu, Haruyoshi Tanaka, et al.
Annals of Surgical Oncology|August 21, 2015
The Prognostic Relevance of Subcarinal Lymph Node Dissection in Esophageal Squamous Cell CarcinomaYukiko Niwa, Masahiko Koike, Masashi Hattori, et al.
In Vivo (Athens, Greece)|April 29, 2021
Different Characteristics of Serum Alfa Fetoprotein and Serum Des-gamma-carboxy Prothrombin in Resected Hepatocellular CarcinomaMasamichi Hayashi, Suguru Yamada, Nao Takano, et al.
International Journal of Oncology|September 6, 2014
Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinomaMitsuro Kanda, Hiroyuki Sugimoto, Shuji Nomoto, et al.
Pageof 27